CTLA4 and cancer: The analyses indicated that cancer types with high KYNU gene expression (>median) generally had elevated gene-based signatures of tumor immune cell infiltrates, including Tregs, as well as immune checkpoint blockade-related genes CD274 (PD-L1), PDCD1 (PD-1), and CTLA4 (Figure 3A).